TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 2 | -1 | -16 | 0 | 0 | 0 | -5 |
| S | %wins | 0 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/4/24 17:23 | 1/2/24 | RCUS | Arcus Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goeltz II Robert C. | CA | O | CFO | S | -40 | 20.00 | 0 | -2 | -4 | 52 | D | ||||||||||||||
6/9/23 16:05 | 6/7/23 | RCUS | Arcus Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goeltz II Robert C. | CA | O | CFO | S | -81 | 20.04 | 0 | -4 | -6 | 59 | D | ||||||||||||||
12/16/22 21:44 | 12/16/22 | RCUS | Arcus Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goeltz II Robert C. | CA | O | CFO | S | -75 | 30.75 | 0 | -2 | -17 | 12 | D | ||||||||||||||
12/20/21 16:22 | 12/16/21 | RCUS | Arcus Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goeltz II Robert C. | CA | O | CFO | S.m | -44 | 40.12 | 0 | -1 | -14 | 7 | D | ||||||||||||||
3/21/17 18:05 | 3/20/17 | CTMX | Cytomx Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Goeltz II Robert C. | CA | O | CFO | S.d | -426 | 19.81 | 5 | -22 | -69 | 10 | D | 52 | 22 | 62 | 64 | 51 | 42 | 29 | 2 | -1 | -16 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |